Ceftazidime Avibactam: A New Antimicrobial Combination Drug To Treat Severe Bacterial Infect

In today’s increasingly antibiotic resistant world, it is more important than ever for doctors to arm themselves with the latest and most effective treatments for serious bacterial infections. Ceftazidime Avibactam is a new antimicrobial combination drug that could revolutionize the way these infections are treated. In this blog post, we will explore this exciting new drug, its uses and potential side effects. We will also discuss how it differs from other antibiotics and why it is so important in the fight against antibiotic resistance. Read on to learn more about this revolutionary new treatment option!

What is Ceftazidime Avibactam?

Ceftazidime Avibactam is a new antimicrobial combination drug that was approved by the FDA in July 2014. The avibactam component reverses the resistance of certain bacteria to ceftazidime, while the ceftazidime component kills the bacteria. This makes ceftazidime avibactam an important new tool for treating severe bacterial infections, including those caused by Enterobacteriaceae (a family of bacteria that includes E. coli and Klebsiella pneumoniae).

How does Ceftazidime Avibactam work?

Ceftazidime Avibactam is a new antimicrobial combination drug that was approved by the FDA in July 2014. The drug is a cephalosporin/beta-lactamase inhibitor combination, and it is indicated for the treatment of severe bacterial infections. Ceftazidime Avibactam works by inhibiting the beta-lactamase enzymes that bacteria use to break down cephalosporin antibiotics. This allows the cephalosporin antibiotic to work more effectively against the bacteria.

What are the side effects of Ceftazidime Avibactam?

Ceftazidime Avibactam is a new antimicrobial combination drug that is used to treat severe bacterial infections. The most common side effects of this drug include nausea, vomiting, diarrhea, and headache. Other less common side effects include rash, dizziness, and fever. If you experience any of these side effects, contact your healthcare provider immediately.

How to take Ceftazidime Avibactam?

Ceftazidime Avibactam (ATM-AVI) is a new combination drug that has shown promise in treating severe bacterial infections. It is a cephalosporin antibiotic combined with avibactam, which is a beta-lactamase inhibitor. This combination makes ATM-AVI resistant to many common bacteria strains that are resistant to other antibiotics.

The recommended dosage of ATM-AVI for adults is 2 g (1 g ceftazidime and 1 g avibactam) intravenously every 8 hours. The infusion should be administered over a period of 30 to 60 minutes. The duration of therapy depends on the severity of the infection and the patient’s response to treatment.

ATM-AVI is generally well tolerated, with the most common side effects being nausea, vomiting, diarrhea, and headache. Serious side effects are rare but can include allergic reactions, kidney damage, and Clostridium difficile colitis.

If you are prescribed ATM-AVI for a severe bacterial infection, be sure to take it exactly as directed by your healthcare provider. Doing so will give you the best chance of overcoming your infection and preventing resistance to this important new antibiotic.

What should I avoid while taking Ceftazidime Avibactam?

Ceftazidime Avibactam should be avoided if patients are allergic to any of the components in the drug. If a patient has ever had anaphylaxis after receiving ceftazidime or avibactam, they should not take this drug. Ceftazidime Avibactam is not recommended for use in children under the age of 18. This drug should also be avoided by pregnant or breastfeeding women.

Read more such content on @ Hidoc Dr | Medical Learning App for Doctors